B. Monge-maillo, F. Norman, I. Cruz, J. Alvar, and R. Lopez-vélez, Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region, PLoS Neglected Tropical Diseases, vol.88, issue.8, p.3021, 2014.
DOI : 10.1371/journal.pntd.0003021.t003

C. Mary, F. Faraut, L. Lascombe, and H. Dumon, Quantification of Leishmania infantum DNA by a Real-Time PCR Assay with High Sensitivity, Journal of Clinical Microbiology, vol.42, issue.11, pp.5249-55, 2004.
DOI : 10.1128/JCM.42.11.5249-5255.2004

D. Basset, F. Faraut, P. Marty, J. Dereure, E. Rosenthal et al., Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature, Microbes and Infection, vol.7, issue.13, pp.1370-1375, 2005.
DOI : 10.1016/j.micinf.2005.06.002

J. Van-griensven, E. Carrillo, R. Lopez-vélez, L. Lynen, and J. Moreno, Leishmaniasis in immunosuppressed individuals, Clinical Microbiology and Infection, vol.20, issue.4, pp.286-99, 2014.
DOI : 10.1111/1469-0691.12556

G. Michel, C. Pomares, B. Ferrua, and M. P. , Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human, Acta Tropica, vol.119, issue.2-3, pp.69-75, 2011.
DOI : 10.1016/j.actatropica.2011.05.012

M. Gramiccia and L. Gradoni, The current status of zoonotic leishmaniases and approaches to disease control, International Journal for Parasitology, vol.35, issue.11-12, pp.1169-80, 2005.
DOI : 10.1016/j.ijpara.2005.07.001

G. Oliva, J. Nieto, F. Manzillo, V. Cappiello, S. Fiorentino et al., A Randomised, Double-Blind, Controlled Efficacy Trial of the LiESP/QA-21 Vaccine in Na??ve Dogs Exposed to Two Leishmania infantum Transmission Seasons, PLoS Neglected Tropical Diseases, vol.25, issue.10, p.3213, 2014.
DOI : 10.1371/journal.pntd.0003213.g010

J. Gangneux, Traitement de la leishmaniose viscérale : modalités récentes, Presse Med, vol.28, pp.2057-66, 1999.

S. Croft, S. Sundar, and A. Fairlamb, Drug Resistance in Leishmaniasis, Clinical Microbiology Reviews, vol.19, issue.1, pp.111-137, 2006.
DOI : 10.1128/CMR.19.1.111-126.2006

L. Gradoni, K. Soteriadou, H. Louzir, A. Dakkak, S. Toz et al., Drug regimens for visceral leishmaniasis in Mediterranean countries, Tropical Medicine & International Health, vol.15, issue.Suppl. 1, pp.1272-1278, 2008.
DOI : 10.1111/j.1365-3156.2008.02144.x

J. Gangneux, A. Sulahian, Y. Garin, and F. Derouin, Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis due to Leishmania infantum, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.90, issue.5, pp.574-581, 1996.
DOI : 10.1016/S0035-9203(96)90330-2

C. Bern, J. Adler-moore, J. Berenguer, M. Boelaert, M. Den-boer et al., Reviews Of Anti???infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis, Clinical Infectious Diseases, vol.43, issue.7, pp.917-941, 2006.
DOI : 10.1086/507530

P. Buffet, É. Rosenthal, J. Gangneux, E. Lightburne, P. Couppié et al., Traitement des leishmanioses en France??: proposition d???un r??f??rentiel consensuel, La Presse M??dicale, vol.40, issue.2, pp.173-84, 2011.
DOI : 10.1016/j.lpm.2010.09.023

J. Gangneux, A. Sulahian, Y. Garin, and F. Derouin, Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum, Journal of Antimicrobial Chemotherapy, vol.40, issue.2, pp.287-296, 1997.
DOI : 10.1093/jac/40.2.287